Real-time enrollment status for this autoimmune disease clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:39 AM UTC
| NCT Number | NCT03816345 |
| Recruiting Status | Recruiting |
| Condition | Autoimmune Disease |
| Phase | PHASE1 |
| Target Enrollment | 300 participants |
| Active Locations | 51 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 31, 2026 (3 weeks ago) |
As of August 27, 2026: Clinical trial NCT03816345 is currently recruiting participants. This phase1 study for autoimmune disease is actively seeking new participants at 51 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03816345 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 51 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03816345 was last updated 3 weeks ago (July 31, 2026). HelloStudys verifies this status automatically.